本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

VITASORA HEALTH LIMITED

0.036
-0.001-2.70%
成交量:26.98万
成交额:9,845.00
市值:5,677.30万
市盈率:-5.55
高:0.037
开:0.036
低:0.036
收:0.037
数据加载中...

公司资料

公司名字:
VITASORA HEALTH LIMITED
交易所:
ASX
成立时间:
1987
员工人数:
30
公司地址:
432 St Kilda Road,Suite 1, Level 9,Melbourne,Victoria,Australia
邮编:
3004
传真:
61 3 9822 7735
简介:
Respiri Limited, a health technology company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; Wholter, a device for home ambulatory recording of nocturnal wheeze and cough; and AirSonea, a digital stethoscope that is paired to a smartphone app to record breathing sounds accurately. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs; and SonoSentry, an over-the-counter wheeze-detection device. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited was incorporated in 1987 and is based in Melbourne, Australia.